India’s Zojila Tunnel Shores up Defense Posture in Himalayas 
The Government Knows the Problem but Life not Getting Better 
Cambodian Cyber Tycoon and ‘Singapore Washing’ The World Health Organization announced on Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease.
“The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy,” the WHO said in a statement.
Advertisement
Up to now, infants have been treated with formulations intended for older children – carrying a greater risk of dosage errors, side effects and toxicity.
“For centuries, malaria has stolen children from their parents, and health, wealth and hope from communities,” WHO chief Tedros Adhanom Ghebreyesus said.
“But today, the story is changing. New vaccines, diagnostic tests, next-generation mosquito nets and effective medicines, including those adapted for the youngest, are helping to turn the tide.
Advertisement
Don't Miss:
-
Lululemon apologises for China event with actor beating Japanese drum on Great Wall
-
Poverty line a limited marker, Hong Kong minister says, as aid focus expands to carers
-
Greece unveils Parthenon’s facade whole for first time in 220 years
-
US, Iran sign peace deal; China’s C919 jets grounded for safety checks: SCMP’s 7 highlights
-
Dragon Boat Festival drums up a buzz as unsettled weather fails to dampen spirits